Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel J Lindner

Showing results (31-40 of 72) with videos related to

Pageof 8
Sort By:
The Journal of Biological Chemistry|March 24, 2007
Effect of inositol hexakisphosphate kinase 2 on transforming growth factor beta-activated kinase 1 and NF-kappaB activationBei H Morrison, Joseph A Bauer, Joseph A Lupica, et al.
Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research|November 23, 2006
Short communication: phase I clinical and gene modulatory evaluation of tamoxifen and IFN-alpha2bSnehal G Thakkar, David Peereboom, Thomas Olencki, et al.
Molecular Cancer Therapeutics|August 5, 2010
Tyrosine phosphatase inhibitor-3 sensitizes melanoma and colon cancer to biotherapeutics and chemotherapeuticsSuman Kundu, Keke Fan, Mingli Cao, et al.
The American Journal of Pathology|September 8, 2007
Tumor suppressive protein gene associated with retinoid-interferon-induced mortality (GRIM)-19 inhibits src-induced oncogenic transformation at multiple levelsSudhakar Kalakonda, Shreeram C Nallar, Ping Gong, et al.
Oligonucleotides|September 19, 2006
Human telomerase RNA degradation by 2'-5'-linked oligoadenylate antisense chimeras in a cell-free system, cultured tumor cells, and murine xenograft modelsJayashree M Paranjape, Da Xu, David M Kushner, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 8, 2005
Sodium stibogluconate interacts with IL-2 in anti-Renca tumor action via a T cell-dependent mechanism in connection with induction of tumor-infiltrating macrophagesKeke Fan, Ming Zhou, Manas K Pathak, et al.
Frontiers in Oncology|January 21, 2026
The CDK inhibitor Roscovitine enhances the therapeutic efficacy of anti-PD-1 in non-small cell lung cancerC Marcela Diaz-Montero, Elise G Holvey-Bates, Patricia A Rayman, et al.
Oncotarget|October 31, 2015
RNase L is a negative regulator of cell migrationShuvojit Banerjee, Geqiang Li, Yize Li, et al.
NPJ Precision Oncology|August 18, 2025
Synergistic effect of MDM2 inhibitors and radiotherapy in endometrial cancerRoberto Vargas, Aaron Petty, Daniel J Lindner, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 23, 2013
Monoallelic loss of tumor suppressor GRIM-19 promotes tumorigenesis in miceSudhakar Kalakonda, Shreeram C Nallar, Sausan Jaber, et al.
Pageof 8

Showing results (31-40 of 72) with videos related to

Sort By:
Pageof 8
The Journal of Biological Chemistry|March 24, 2007
Effect of inositol hexakisphosphate kinase 2 on transforming growth factor beta-activated kinase 1 and NF-kappaB activationBei H Morrison, Joseph A Bauer, Joseph A Lupica, et al.
Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research|November 23, 2006
Short communication: phase I clinical and gene modulatory evaluation of tamoxifen and IFN-alpha2bSnehal G Thakkar, David Peereboom, Thomas Olencki, et al.
Molecular Cancer Therapeutics|August 5, 2010
Tyrosine phosphatase inhibitor-3 sensitizes melanoma and colon cancer to biotherapeutics and chemotherapeuticsSuman Kundu, Keke Fan, Mingli Cao, et al.
The American Journal of Pathology|September 8, 2007
Tumor suppressive protein gene associated with retinoid-interferon-induced mortality (GRIM)-19 inhibits src-induced oncogenic transformation at multiple levelsSudhakar Kalakonda, Shreeram C Nallar, Ping Gong, et al.
Oligonucleotides|September 19, 2006
Human telomerase RNA degradation by 2'-5'-linked oligoadenylate antisense chimeras in a cell-free system, cultured tumor cells, and murine xenograft modelsJayashree M Paranjape, Da Xu, David M Kushner, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 8, 2005
Sodium stibogluconate interacts with IL-2 in anti-Renca tumor action via a T cell-dependent mechanism in connection with induction of tumor-infiltrating macrophagesKeke Fan, Ming Zhou, Manas K Pathak, et al.
Frontiers in Oncology|January 21, 2026
The CDK inhibitor Roscovitine enhances the therapeutic efficacy of anti-PD-1 in non-small cell lung cancerC Marcela Diaz-Montero, Elise G Holvey-Bates, Patricia A Rayman, et al.
Oncotarget|October 31, 2015
RNase L is a negative regulator of cell migrationShuvojit Banerjee, Geqiang Li, Yize Li, et al.
NPJ Precision Oncology|August 18, 2025
Synergistic effect of MDM2 inhibitors and radiotherapy in endometrial cancerRoberto Vargas, Aaron Petty, Daniel J Lindner, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 23, 2013
Monoallelic loss of tumor suppressor GRIM-19 promotes tumorigenesis in miceSudhakar Kalakonda, Shreeram C Nallar, Sausan Jaber, et al.
Pageof 8